193
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Discontinuation of Everolimus Due to Related and Unrelated Adverse Events in Cancer Patients: A Meta-Analysis

, ORCID Icon &
Pages 552-561 | Received 17 Mar 2017, Accepted 16 Jun 2017, Published online: 11 Aug 2017
 

ABSTRACT

A meta-analysis of randomized controlled trials (RCTs) was performed to examine the risk of everolimus discontinuation due to related and unrelated adverse events (AE) in cancer patients. Fifteen RCTs were analyzed that compared everolimus to placebo and reported discontinuation due to AE with everolimus (related and unrelated to everolimus) and placebo (unrelated to everolimus). Incidence of discontinuation with everolimus due to AE and placebo was 12.3% and 4.7% respectively. Relative risk of everolimus discontinuation due to related AE was 2.60. Risk of discontinuation varied by tumor type, however everolimus dose or concomitant chemotherapy was not significant.

Acknowledgment

Study concept and design: Dr. Wu

Acquisition of data: Dr. Rogers

Analysis and interpretation of data: Dr. Wu, Dr. Rogers

Drafting of the manuscript: Dr. Rogers, Dr. Garcia

Critical revision of the manuscript for important intellectual

content: Dr. Wu, Dr. Rogers and Dr. Garcia

Statistical analysis: Dr. Wu

Administrative, technical, or material support: none

Study supervision: Dr. Wu

Funding/Material Support: none

Dr. Wu has full access to all of the data in the study and takes

responsibility for the integrity of the data and the accuracy of the data analysis.

Declaration of interest

Dr. Wu reported being a speaker for Pfizer and Novartis. No other authors reported conflicts of interest.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,193.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.